The interventions with trial support, and the much longer list without
We separate what is supported, what is reasonable, and what is folklore, and we do not pretend the boundaries are crisp.
Archive — April 2025
Page 2 of 5 of this archive, newest first.
How a claim degrades between the bench and the listing
Every step between the laboratory report and the product page removes information, and the badge is the last step.
India declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Xianning export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A supplier suspends shipping to Denmark after 19 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Site selection when the tissue has already changed
The evidence base here is the insulin injection-technique literature, which is large and transfers well on tissue questions.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Argentina pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
What changed at QSC in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Janoshik result on a Guangzhou retatrutide lot lands 2.2 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
A tested vial is evidence about a vial
What a laboratory can and cannot know about the provenance, storage history and representativeness of what lands on its bench.
Six words a verification badge would need to mean anything
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Calibrated, qualified, accredited: three words that are not synonyms
An assay against a quantitative reference standard measures how much is present. Area per cent measures what proportion of the visible material is the parent. Only the first…
The 19-day notice: how a compounding wind-down works in Turkey
The document is four pages. Three of them are about dates.
Chengdu export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Denmark declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Where the solvent front ends is a decision, not a fact
Regulated pharmaceutical practice has explicit reporting, identification and qualification thresholds. This trade has none, which is why a purity figure carries no…
Continued treatment against continued placebo: the comparison that settled it
What was withdrawn, from whom, after how long, and what was measured afterwards.
The relabeller trading as Vantris Bio closes after 16 years
A proper account of an operation that existed, and of what closing it cost.
STEP 2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The Netherlands caps tirzepatide prescribing to 4 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Two sessions a week, and the evidence behind the prescription
One randomised trial has combined a GLP-1 receptor agonist with supervised exercise. Its result is the single most useful piece of evidence in this area.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
Switzerland declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Wuxi export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
The out-of-range flag is a statistical convention with a printer attached
A twelve-analyte panel in a perfectly healthy person has roughly even odds of producing at least one flagged result.
The mechanism behind the mechanism
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
The question no chromatogram has ever answered
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
The online reseller trading as Adamant Research Supply closes after 6 years
A proper account of an operation that existed, and of what closing it cost.
Italy caps semaglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at KP in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
France pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
How much water: the question with no single right answer
The diluent choice affects preservation and in-use period rather than the arithmetic — but the wrong choice for a multi-dose vial is a sterility decision, not a convenience…
The specification sheet says 500,000. The report says conforms.
Calibration drift is real, unremarkable, and the reason serious laboratories run internal standards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The United Kingdom pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.